# E-DRUG: Re: Alert - Tranylcypromine/trifluoperazine combination **URL:** \ **Category:** e-drug\ **Created:** [June 14, 1999, 7:19pm UTC](https://talk.edrugplus.org/t/e-drug-re-alert-tranylcypromine-trifluoperazine-combination/5315 "1999-06-14T19:19:06Z")\ **Posts on this page:** 1\ **Page:** 1
**Author:** ![lo1](https://avatars.discourse-cdn.com/v4/letter/l/e68b1a/32.png) [@lo1](https://talk.edrugplus.org/u/lo1)\ **Post date:** [June 14, 1999, 7:19pm UTC](https://talk.edrugplus.org/t/e-drug-re-alert-tranylcypromine-trifluoperazine-combination/5315/1 "1999-06-14T19:19:06Z")
E-drug: Re: Alert - Tranylcypromine/trifluoperazine combination ---------------------------------------------------------- Dear colleagues, One of the major problems is that the "free" combination of antipsychotics and antidepressants is still quite popular with psychiatrists, even though the rationality of the combination is quite doubtful. See: Kiivet et al., Br J Clin Pharmacol 1995;40:467-76: 42% in Spain, 75% in Estonia, and even 30% in Sweden. Dr.L.Offerhaus Koedijklaan 1a, NL-1406KW Bussum, The Netherlands Phone: +31-35-6923288. Fax: +31-35-6923290 E-mail: LO@EURONET.NL CompuServe: 71530,15 Eur J Clin Pharmacol ONLY: POB 75552, NL-1070AN Amsterdam, The Netherlands -- Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'. Mail administrative requests to `majordomo@usa.healthnet.org'. For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.